HLA-C and neoplasm: In contrast, immune-inflamed tumors are characterized by a TME rich in interferon-gamma (IFN-γ), a high tumor mutational burden, a large population of TILs, and an elevated expression of major histocompatibility complex (MHC) class I/II in tumor cells [16,17,18,19,20].